In Vitro Activities of Gemifloxacin (SB 265805, LB20304) against Recent Clinical Isolates of Chlamydia pneumoniae

We compared the in vitro activity of gemifloxacin, a new quinolone antibiotic, to the activities of levofloxacin, moxifloxacin, trovafloxacin, erythromycin, and doxycycline against 20 isolates of Chlamydia pneumoniae. Gemifloxacin was the most active quinolone tested, with a MIC at which 90% of the...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Roblin, Patricia M., Reznik, Tamara, Kutlin, Andrei, Hammerschlag, Margaret R.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1999
Assuntos:	Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89566/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10543770/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.11.2806
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!